Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: A case report

Scandinavian Journal of Infectious Diseases

Volumn 46, Issue 1, 2014, Pages 63-65

  Langholz Kristensen, Kristina ^a   Dragsted, Ulrik Bak ^a  

^a ROSKILDE HOSPITAL   (Denmark)

Author keywords

Malaria; Plasmodium vivax; Primaquine; Recurrence; Resistance

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; HYDROXYCHLOROQUINE; PRIMAQUINE;

ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD CHEMISTRY; BLOOD CULTURE; BODY WEIGHT; CASE REPORT; CHEMOPROPHYLAXIS; CHILL; DRUG EFFICACY; DRUG MEGADOSE; FEVER; FOLLOW UP; HUMAN; LABORATORY TEST; MALARIA FALCIPARUM; MALE; MIDDLE AGED; NECK PAIN; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; RECURRENT INFECTION; RELAPSE; SHOULDER PAIN; SINGLE DRUG DOSE; SYMPTOM; TRAVEL; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIMALARIALS; DRUG RESISTANCE; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; PLASMODIUM VIVAX; PRIMAQUINE; RECURRENCE;

EID: 84890899825     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2013.822093     Document Type: Article

References (10)

1. Maguire JD, Baird JK. The 'Non-falciparum' malarias: The roles of epidemiology, parasite biology, clinical syndromes, complications and diagnostic rigour in guiding therapeutic strategies. Ann Trop Med Parasitol 2010;104: 283-301
2. Bottieau E, Clerinx J, Van Den Enden E, Van Esbroeck M, Colebunders R, Van Gompel A, et al. Imported non- Plasmodium falciparum malaria: A fi ve-year prospective study in a European referral center. Am J Trop Med Hyg 2006;75: 133-8
3. Whitty CJ, Chiodini PL, Lalloo DG. I nvestigation and treatment of imported malaria in non-endemic countries. BMJ 2013;346: F2900
4. John GK, Douglas NM, von Seidlein L, Nosten F, Baird JK, White NJ, et al. Primaquine radical cure of Plasmodium vivax: A critical review of the literature. Malar J 2012;11: 280
5. Baird J K, Hoffman S L. P rimaquine therapy for malaria. Clin Infect Dis 2004;39: 1336-45
6. Price RN, Douglas NM, Anstey NM, von Seidlein L. Plasmodium vivax treatments: What are we looking for? Curr Opin Infect Dis 2011;24: 578-85
7. S chwartz E, Regev-Yochay G, Kurnik D. S hort report: A consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria. Am J Trop Med Hyg 2000 ; 62: 393-5
8. Fernando D, Rodrigo C, Rajapakse S. P rimaquine in vivax malaria: An update and review on management issues. Malar J 2011;10: 351
9. World Health Organization. G uidelines for the treatment of malaria. Second ed. Geneva: WHO;2010
10. Alving AS, Johnson C F, Tarlov AR, Brewer G J, Kellermeyer RW, Carson PE. Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration: A preliminary report. Bull World Health Organ 1960;22: 621-31